Metformin Use and Risk of Incident Hearing Loss Among Participants With Diabetes: A UK Biobank Cohort Study
Diabetes, Obesity and Metabolism · 2026-12 · 28 (12) · 11178-11193
DOI: 10.1111/dom.71306 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 08.09.2026. Verfasst von Xijian Xin und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Metformin, Hypoglycemic Agents, Hearing Loss, Diabetes Mellitus, Type 2. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Shandong Provincial Natural Science Foundation, Natural Science Foundation of Shandong Province.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
To investigate the association between baseline metformin use and incident hearing loss among participants with diabetes in the UK Biobank. Materials and Methods This study included participants from the UK Biobank who had been diagnosed with diabetes before baseline and had no evidence of hearing loss ( N = 24 981). Metformin use was determined based on self‐reported medication use at the baseline assessment. Incident hearing loss was ascertained using a composite definition based on speech‐reception‐threshold estimate, hearing aid use, cochlear implantation and relevant ICD‐10 diagnoses during follow‐up. Cox proportional hazards models were used, with analyses stratified by sex and adjusted for demographic, lifestyle, socioeconomic, clinical factors, noise exposure, use of antidiabetic medications and renal function.
Results
During approximately 12 years of follow‐up, 725 and 385 incident hearing loss events were observed among male and female participants, respectively. Sex‐stratified analyses showed that, among men with diabetes, baseline metformin use was associated with a lower risk of incident hearing loss (fully adjusted model: hazard ratio [95% confidence interval], 0.846 [0.725–0.987], p = 0.0339), and this association remained generally stable across multiple sensitivity analyses. In contrast, among women with diabetes, no statistically significant association was observed between metformin use and the risk of incident hearing loss (fully adjusted model: hazard ratio [95% confidence interval], 0.977 [0.790–1.208], p = 0.8290). Further interaction analysis showed that the interaction term between metformin use and sex was not statistically significant ( p for interaction = 0.260).
Conclusions
In participants with diabetes from the UK Biobank, baseline metformin use was associated with a lower risk of incident hearing loss among men, whereas no significant association was observed among women. However, the interaction term between metformin use and sex was not statistically significant; therefore, it cannot yet be concluded that this association differed by sex.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
- NHC Key Laboratory of Otorhinolaryngology, Shandong University, Jinan, Shandong, China.
- Department of Nutrition, Qilu Hospital of Shandong University, Jinan, Shandong, China.
- Clinical Epidemiology Unit, Qilu Hospital of Shandong University, Jinan, Shandong, China.
- Department of Epidemiology and Health Statistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
- Clinical Research Center of Shandong University, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
ORCID-Profile: Xijian Xin
Förderung
- Shandong Provincial Natural Science Foundation
- Natural Science Foundation of Shandong Province
Zitieren
APA
Xin, X., Zhang, K., Yu, W., Liu, J., Gao, L., Li, M., Zhu, W., Jia, W., Hou, B., Liu, Y., Bai, H., Chen, L., Zhang, H., Lv, M., & Xu, X. (2026). Metformin Use and Risk of Incident Hearing Loss Among Participants With Diabetes: A UK Biobank Cohort Study. Diabetes, Obesity and Metabolism, 28(12), 11178-11193. https://doi.org/10.1111/dom.71306
Vancouver
Xin X, Zhang K, Yu W, Liu J, Gao L, Li M, et al. Metformin Use and Risk of Incident Hearing Loss Among Participants With Diabetes: A UK Biobank Cohort Study. Diabetes, Obesity and Metabolism. 2026;28(12):11178-11193. doi:10.1111/dom.71306
BibTeX
@article{Xin2026,
author = {Xin, Xijian and Zhang, Kun and Yu, Wenhe and Liu, Jiaxin and Gao, Liying and Li, Mingqi and Zhu, Wenwen and Jia, Wenming and Hou, Bo and Liu, Ying and Bai, Hao and Chen, Liyong and Zhang, Hanbing and Lv, Ming and Xu, Xinbo},
title = {Metformin Use and Risk of Incident Hearing Loss Among Participants With Diabetes: A UK Biobank Cohort Study},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
volume = {28},
number = {12},
pages = {11178--11193},
doi = {10.1111/dom.71306}
}
EUVIMED